SB

Syntis Bio

Biotechnology · Boston, Massachusetts, United States

About

They unlocking the full therapeutic potential of the small intestine, addressing global healthcare challenges ranging from rare genetic disorders to most prevalent conditions. They are rapidly advancing a pipeline of drug candidates in multiple therapeutic areas, starting with obesity.

Company details may include data from People Data Labs, licensed CC BY 4.0.